RA
Rosalind Advisors Portfolio holdings
AUM
$207M
This Quarter Return
+12.68%
1 Year Return
+62.29%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$107M
AUM Growth
+$107M
(-11%)
Cap. Flow
-$13.7M
Cap. Flow
% of AUM
-12.84%
Top 10 Holdings %
Top 10 Hldgs %
58.36%
Holding
41
New
11
Increased
2
Reduced
11
Closed
7
Top Buys
| 1 |
CYBN
Cybin
CYBN
|
$5.77M |
| 2 |
ABVX
Abivax
ABVX
|
$5.41M |
| 3 |
Clearside Biomedical
CLSD
|
$3.97M |
| 4 |
Outlook Therapeutics
OTLK
|
$3.72M |
| 5 |
Unicycive Therapeutics
UNCY
|
$2.59M |
Top Sells
| 1 |
Astria Therapeutics
ATXS
|
$8.67M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$5.78M |
| 3 |
Sarepta Therapeutics
SRPT
|
$5.54M |
| 4 |
Cellectar Biosciences
CLRB
|
$5.51M |
| 5 |
Lyra Therapeutics
LYRA
|
$4.63M |
Sector Composition
| 1 | Healthcare | 100% |
